NCT05009875View on ClinicalTrials.gov

Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia

NACompletedINTERVENTIONAL

Enrollment

286

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

July 17, 2024

Study Completion Date

August 1, 2024

Conditions

Osteopenia

Interventions

OTHER

Medical Food SBD111

Two capsules administered twice daily with morning and evening meals for 52 weeks

OTHER

Placebo

Two capsules administered twice daily with morning and evening meals for 52 weeks

Trial Locations (1)

4006

RDC Clinical, Newstead

All Listed Sponsors

lead

Solarea Bio, Inc

INDUSTRY

NCT05009875 - Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia | Biotech Hunter | Biotech Hunter